Logo image of NPCE

NEUROPACE INC (NPCE) Stock Fundamental Analysis

USA - NASDAQ:NPCE - US6412881053 - Common Stock

9.86 USD
-0.27 (-2.67%)
Last: 10/30/2025, 8:00:02 PM
10.01 USD
+0.15 (+1.52%)
After Hours: 10/30/2025, 8:00:02 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to NPCE. NPCE was compared to 189 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of NPCE have multiple concerns. NPCE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NPCE had negative earnings in the past year.
In the past year NPCE has reported a negative cash flow from operations.
NPCE had negative earnings in each of the past 5 years.
In the past 5 years NPCE always reported negative operating cash flow.
NPCE Yearly Net Income VS EBIT VS OCF VS FCFNPCE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

NPCE's Return On Assets of -24.45% is in line compared to the rest of the industry. NPCE outperforms 46.03% of its industry peers.
NPCE has a Return On Equity of -133.46%. This is in the lower half of the industry: NPCE underperforms 66.67% of its industry peers.
Industry RankSector Rank
ROA -24.45%
ROE -133.46%
ROIC N/A
ROA(3y)-33.52%
ROA(5y)-34.1%
ROE(3y)-211.19%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NPCE Yearly ROA, ROE, ROICNPCE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 200 -200

1.3 Margins

NPCE's Gross Margin of 75.74% is amongst the best of the industry. NPCE outperforms 87.83% of its industry peers.
In the last couple of years the Gross Margin of NPCE has remained more or less at the same level.
NPCE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 75.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.03%
GM growth 5Y0.65%
NPCE Yearly Profit, Operating, Gross MarginsNPCE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

3

2. Health

2.1 Basic Checks

NPCE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NPCE has been increased compared to 1 year ago.
Compared to 5 years ago, NPCE has more shares outstanding
The debt/assets ratio for NPCE is higher compared to a year ago.
NPCE Yearly Shares OutstandingNPCE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M
NPCE Yearly Total Debt VS Total AssetsNPCE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

NPCE has an Altman-Z score of -3.87. This is a bad value and indicates that NPCE is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -3.87, NPCE is doing worse than 66.67% of the companies in the same industry.
A Debt/Equity ratio of 3.02 is on the high side and indicates that NPCE has dependencies on debt financing.
NPCE has a Debt to Equity ratio of 3.02. This is amonst the worse of the industry: NPCE underperforms 85.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.02
Debt/FCF N/A
Altman-Z -3.87
ROIC/WACCN/A
WACC8.68%
NPCE Yearly LT Debt VS Equity VS FCFNPCE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

2.3 Liquidity

A Current Ratio of 5.47 indicates that NPCE has no problem at all paying its short term obligations.
With an excellent Current ratio value of 5.47, NPCE belongs to the best of the industry, outperforming 80.42% of the companies in the same industry.
NPCE has a Quick Ratio of 4.51. This indicates that NPCE is financially healthy and has no problem in meeting its short term obligations.
NPCE has a better Quick ratio (4.51) than 79.37% of its industry peers.
Industry RankSector Rank
Current Ratio 5.47
Quick Ratio 4.51
NPCE Yearly Current Assets VS Current LiabilitesNPCE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.94% over the past year.
Looking at the last year, NPCE shows a very strong growth in Revenue. The Revenue has grown by 23.32%.
Measured over the past years, NPCE shows a quite strong growth in Revenue. The Revenue has been growing by 16.67% on average per year.
EPS 1Y (TTM)22.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)23.32%
Revenue growth 3Y20.93%
Revenue growth 5Y16.67%
Sales Q2Q%22.14%

3.2 Future

NPCE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.17% yearly.
NPCE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.68% yearly.
EPS Next Y8.47%
EPS Next 2Y11.97%
EPS Next 3Y19.33%
EPS Next 5Y21.17%
Revenue Next Year20.22%
Revenue Next 2Y12.92%
Revenue Next 3Y16.87%
Revenue Next 5Y18.68%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
NPCE Yearly Revenue VS EstimatesNPCE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M
NPCE Yearly EPS VS EstimatesNPCE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -10 -20 -30

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NPCE. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NPCE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NPCE Price Earnings VS Forward Price EarningsNPCE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NPCE Per share dataNPCE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

NPCE's earnings are expected to grow with 19.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.97%
EPS Next 3Y19.33%

More info and screens

0

5. Dividend

5.1 Amount

NPCE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEUROPACE INC

NASDAQ:NPCE (10/30/2025, 8:00:02 PM)

After market: 10.01 +0.15 (+1.52%)

9.86

-0.27 (-2.67%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-12 2025-08-12/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners60.77%
Inst Owner Change0.11%
Ins Owners2.49%
Ins Owner Change0.78%
Market Cap326.17M
Revenue(TTM)88.57M
Net Income(TTM)-25942000
Analysts84.29
Price Target17.19 (74.34%)
Short Float %4.31%
Short Ratio6.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.08%
Min EPS beat(2)-14.56%
Max EPS beat(2)14.72%
EPS beat(4)3
Avg EPS beat(4)12.89%
Min EPS beat(4)-14.56%
Max EPS beat(4)30.58%
EPS beat(8)7
Avg EPS beat(8)16.32%
EPS beat(12)11
Avg EPS beat(12)15.67%
EPS beat(16)11
Avg EPS beat(16)8.03%
Revenue beat(2)1
Avg Revenue beat(2)0.48%
Min Revenue beat(2)-0.11%
Max Revenue beat(2)1.08%
Revenue beat(4)2
Avg Revenue beat(4)2.14%
Min Revenue beat(4)-0.6%
Max Revenue beat(4)8.22%
Revenue beat(8)6
Avg Revenue beat(8)3.61%
Revenue beat(12)10
Avg Revenue beat(12)7.12%
Revenue beat(16)12
Avg Revenue beat(16)4.63%
PT rev (1m)0%
PT rev (3m)-2.48%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.95%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.34%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.9%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.68
P/FCF N/A
P/OCF N/A
P/B 16.78
P/tB 16.78
EV/EBITDA N/A
EPS(TTM)-0.84
EYN/A
EPS(NY)-0.71
Fwd EYN/A
FCF(TTM)-0.5
FCFYN/A
OCF(TTM)-0.49
OCFYN/A
SpS2.68
BVpS0.59
TBVpS0.59
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -24.45%
ROE -133.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 75.74%
FCFM N/A
ROA(3y)-33.52%
ROA(5y)-34.1%
ROE(3y)-211.19%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.03%
GM growth 5Y0.65%
F-Score5
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 3.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18.69%
Cap/Sales 0.39%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.47
Quick Ratio 4.51
Altman-Z -3.87
F-Score5
WACC8.68%
ROIC/WACCN/A
Cap/Depr(3y)83.43%
Cap/Depr(5y)79.26%
Cap/Sales(3y)0.66%
Cap/Sales(5y)0.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y8.47%
EPS Next 2Y11.97%
EPS Next 3Y19.33%
EPS Next 5Y21.17%
Revenue 1Y (TTM)23.32%
Revenue growth 3Y20.93%
Revenue growth 5Y16.67%
Sales Q2Q%22.14%
Revenue Next Year20.22%
Revenue Next 2Y12.92%
Revenue Next 3Y16.87%
Revenue Next 5Y18.68%
EBIT growth 1Y19.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year33.5%
EBIT Next 3Y26.38%
EBIT Next 5YN/A
FCF growth 1Y43.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y44.29%
OCF growth 3YN/A
OCF growth 5YN/A

NEUROPACE INC / NPCE FAQ

Can you provide the ChartMill fundamental rating for NEUROPACE INC?

ChartMill assigns a fundamental rating of 2 / 10 to NPCE.


Can you provide the valuation status for NEUROPACE INC?

ChartMill assigns a valuation rating of 0 / 10 to NEUROPACE INC (NPCE). This can be considered as Overvalued.


Can you provide the profitability details for NEUROPACE INC?

NEUROPACE INC (NPCE) has a profitability rating of 1 / 10.


What is the earnings growth outlook for NEUROPACE INC?

The Earnings per Share (EPS) of NEUROPACE INC (NPCE) is expected to grow by 8.47% in the next year.